Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: The role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis

Molecular Biology of the Cell

Volumn 19, Issue 5, 2008, Pages 2278-2288

  Yan, Wei ^a   Bentley, Brooke ^a   Shao, Rong ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ANGIOGENIC FACTOR; BETA3 INTEGRIN; BETA5 INTEGRIN; CYTOPLASM PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; IMATINIB; MATRIGEL; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL LINE; CELL PROLIFERATION; CYTOPLASM; CYTOSKELETON; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MICE, SCID; MODELS, BIOLOGICAL; MUTANT PROTEINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-ABL; PYRIMIDINES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48249099239     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-10-1068     Document Type: Article

References (50)

1. Abedi, H., and Zachary, I. (1997). Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272, 15442-15451.
2. Abu-Ghazaleh, R., Kabir, J., Jia, H., Lobo, M., and Zachary, I. (2001). Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and antiapoptosis in endothelial cells. Biochem. J. 360, 255-264.
3. Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G., and Cheresh, D. A. (2003). Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301, 94-96.
4. Bergers, G., and Benjamin, L. E. (2003). Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, 401-410.
5. Blystone, S. D., Lindberg, F. P., Williams, M. P., McHugh, K. P., and Brown, E. J. (1996). Inducible tyrosine phosphorylation of the beta3 integrin requires the alphaV integrin cytoplasmic tail. J. Biol. Chem. 271, 31458-31462.
6. Brooks, P. C., Clark, R. A., and Cheresh, D. A. (1994a). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569-571.
7. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994b). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
8. Bussolino, F., Mantovani, A., and Persico, G. (1997). Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22, 251-256.
9. Byzova, T. V., Goldman, C. K., Pampori, N., Thomas, K. A., Bett, A., Shattil, S. J., and Plow, E. F. (2000). A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell 6, 851-860.
10. Echarri, A., and Pendergast, A. M. (2001). Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Curr. Biol. 11, 1759-1765.
11. Eliceiri, B. P. (2001). Integrin and growth factor receptor crosstalk. Circ. Res. 89, 1104-1110.
12. Eliceiri, B. P., Paul, R., Schwartzberg, P. L., Hood, J. D., Leng, J., and Cheresh, D. A. (1999). Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4, 915-924.
13. Eliceiri, B. P., Puente, X. S., Hood, J. D., Stupack, D. G., Schlaepfer, D. D., Huang, X. Z., Sheppard, D., and Cheresh, D. A. (2002). Src-mediated coupling of focal adhesion kinase to integrin alpha(v) beta5 in vascular endothelial growth factor signaling. J. Cell Biol. 157, 149-160.
14. Fahmy, R. G., Dass, C. R., Sun, L. Q., Chesterman, C. N., and Khachigian, L. M. (2003). Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat. Med. 9, 1026-1032.
15. Ferrari, G., Pintucci, G., Seghezzi, G., Hyman, K., Galloway, A. C., and Mignatti, P. (2006). VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA 103, 17260-17265.
16. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.
17. Folkman, J. (1996). Tumor angiogenesis and tissue factor. Nat. Med. 2, 167-168.
18. Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. (1995). Definition of two angiogenic pathways by distinct alpha v integrins. Science 270, 1500-1502.
19. Guo, D., Jia, Q., Song, H. Y., Warren, R. S., and Donner, D. B. (1995). Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270, 6729-6733.
20. Hagerstrand, D., Hesselager, G., Achterberg, S., Wickenberg Bolin, U., Kowanetz, M., Kastemar, M., Heldin, C. H., Isaksson, A., Nister, M., and Ostman, A. (2006). Characterization of an imatinib-sensitive subset of high-grade human glioma cultures. Oncogene 25, 4913-4922.
21. Hanahan, D., and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
22. Hauck, C. R., Hsia, D. A., and Schlaepfer, D. D. (2002). The focal adhesion kinase - a regulator of cell migration and invasion. IUBMB Life 53, 115-119.
23. Jallal, H., Valentino, M. L., Chen, G., Boschelli, F., Ali, S., and Rabbani, S. A. (2007). A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo. Cancer Res. 67, 1580-1588.
24. Jiang, X., Saw, K. M., Eaves, A., and Eaves, C. (2007). Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.[see comment]. J. Natl. Cancer Instit. 99, 680-693.
25. Jones, P. L., Crack, J., and Rabinovitch, M. (1997). Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J. Cell Biol. 139, 279-293.
26. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844.
27. Le Bras, S., Moon, C., Foucault, I., Breittmayer, J. P., and Deckert, M. (2007). Abl-SH3 binding protein 2, 3BP2, interacts with CIN85 and HIP-55. FEBS Lett. 581, 967-974.
28. Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., and Strawn, L. M. (1996). Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615-1620.
29. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22.
30. O'Neill, A. J., Cotter, T. G., Russell, J. M., and Gaffney, E. F. (1997). Abl expression in human fetal and adult tissues, tumours, and tumour microvessels. J. Pathol. 183, 325-329.
31. Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., and Pendergast, A. M. (1999). c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13, 2400-2411.
32. Polnaszek, N., Kwabi-Addo, B., Peterson, L. E., Ozen, M., Greenberg, N. M., Ortega, S., Basilico, C., and Ittmann, M. (2003). Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res. 63, 5754-5760.
33. Prewett, M. et al. (1999). Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 59, 5209-5218.
34. Price, N. D., Trent, J., El-Naggar, A. K., Cogdell, D., Taylor, E., Hunt, K. K., Pollock, R. E., Hood, L., Shmulevich, I., and Zhang, W. (2007). Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc. Natl. Acad. Sci. USA 104, 3414-3419.
35. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
36. Schneller, M., Vuori, K., and Ruoslahti, E. (1997). Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J. 16, 5600-5607.
37. Schumacher, J. J., Dings, R. P., Cosin, J., Subramanian, I. V., Auersperg, N., and Ramakrishnan, S. (2007). Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells. Cancer Res. 67, 3683-3690.
38. Senger, D. R., Ledbetter, S. R., Claffey, K. P., Papadopoulos-Sergiou, A., Peruzzi, C. A., and Detmar, M. (1996). Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149, 293-305.
39. Shao, R., and Guo, X. (2004). Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem. Biophys. Res. Commun. 321, 788-794.
40. Sieg, D. J., Hauck, C. R., Ilic, D., Klingbeil, C. K., Schaefer, E., Damsky, C. H., and Schlaepfer, D. D. (2000). FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2, 249-256.
41. Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., and Bussolino, F. (1999). Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 18, 882-892.
42. Soverini, S. et al. (2006). Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia. Clin. Cancer Res. 12, 7374-7379.
43. Sun, J. et al. (2005). Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. Oncogene 24, 4701-4709.
44. Swords, R., Alvarado, Y., and Giles, F. (2007). Novel Abl kinase inhibitors in chronic myeloid leukemia in blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia. Clin. Lymphoma Myeloma 7(Suppl. 3), S113-S119.
45. Tei, K., Kawakami-Kimura, N., Taguchi, O., Kumamoto, K., Higashiyama, S., Taniguchi, N., Toda, K., Kawata, R., Hisa, Y., and Kannagi, R. (2002). Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res. 62, 6289-6296.
46. Weis, S. M., Lindquist, J. N., Barnes, L. A., Lutu-Fuga, K. M., Cui, J., Wood, M. R., and Cheresh, D. A. (2007). Cooperation between VEGF and beta3 integrin during cardiac vascular development. Blood 109, 1962-1970.
47. Wheeler-Jones, C., Abu-Ghazaleh, R., Cospedal, R., Houliston, R. A., Martin, J., and Zachary, I. (1997). Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett. 420, 28-32.
48. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
49. Yoshida, A., Anand-Apte, B., and Zetter, B. R. (1996). Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13, 57-64.
50. Zeng, L., Xiao, Q., Margariti, A., Zhang, Z., Zampetaki, A., Patel, S., Capogrossi, M. C., Hu, Y., and Xu, Q. (2006). HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J. Cell Biol. 174, 1059-1069.